Kiromic BioPharma, Inc. (KRBPQ)
OTCMKTS · Delayed Price · Currency is USD
0.0050
0.00 (0.00%)
Oct 7, 2025, 9:30 AM EDT
Kiromic BioPharma Market Cap
Kiromic BioPharma has a market cap or net worth of $7.85 thousand as of October 8, 2025. Its market cap has decreased by -99.80% in one year.
Market Cap
7.85K
Enterprise Value
13.44M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 16, 2020, Kiromic BioPharma's market cap has decreased from 84.33M to 7.85K, a decrease of -99.99%. That is a compound annual growth rate of -84.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2025 | 7.85K | -99.43% |
| Dec 31, 2024 | 1.38M | 26.04% |
| Dec 29, 2023 | 1.09M | -66.79% |
| Dec 30, 2022 | 3.30M | -86.04% |
| Dec 31, 2021 | 23.62M | -61.97% |
| Dec 31, 2020 | 62.11M | -26.35% |
| Oct 16, 2020 | 84.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 683.67M |
| Glass House Brands | 645.74M |
| Veradigm | 528.17M |
| Northwest Biotherapeutics | 379.57M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 314.22M |
| American Oncology Network | 274.14M |
| Silence Therapeutics | 242.78M |